The use of claims databases for outcomes research: Rationale, challenges, and strategies

被引:137
作者
Motheral, BR [1 ]
Fairman, KA [1 ]
机构
[1] EXPRESS SCRIPTS INC, OUTCOMES RES, MARYLAND HTS, MO USA
关键词
claims database research; outcomes research;
D O I
10.1016/S0149-2918(97)80122-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Health care payers and policy makers need information about the cost and effectiveness of medical treatments, While randomized controlled trials historically are the primary source of medical information, they are expensive and labor-intensive, and often have limited utility for answering questions about ''real-world'' patient populations. These problems have led to an increasing reliance on claims database research in making policy decisions about treatment options. However, both researchers and decision makers should recognize the limitations and unique features of claims databases. Recommendations for avoiding or minimizing threats to internal validity, construct validity, and external validity are: (1) use of a study design that includes comparisons; (2) ensuring that the study design and conclusions are consistent with the database; (3) a priori conceptual modeling of the research question; (4) use of appropriate constructs; (5) explicit examination of alternative explanations for study findings; (6) sensitivity analyses of key assumptions; (7) awareness of the distinction between statistical and practical significance of findings; (8) generalization only when appropriate; and (9) reporting of relevant in formation, Given that any study design or data source has limitations, we hope that this paper will encourage a philosophy of methodological pluralism in outcomes research. Awareness and accurate reporting of validity issues will strengthen and extend the information resources currently available to decision makers.
引用
收藏
页码:346 / 366
页数:21
相关论文
共 76 条
  • [21] Concomitant use of anxiolytics and hypnotics with selective serotonin reuptake inhibitors
    Gregor, KJ
    Riley, JA
    Downing, DK
    [J]. CLINICAL THERAPEUTICS, 1996, 18 (03) : 521 - 527
  • [22] MORTALITY AFTER CORONARY ANGIOPLASTY AND CORONARY-ARTERY BYPASS-SURGERY (THE NATIONAL MEDICARE EXPERIENCE)
    HARTZ, AJ
    KUHN, EM
    PRYOR, DB
    KRAKAUER, H
    YOUNG, M
    HEUDEBERT, G
    RIMM, AA
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (02) : 179 - 185
  • [23] HEFNER DL, 1979, STUDY DETERMINE COST
  • [24] AVOIDING BIAS IN THE CONDUCT AND REPORTING OF COST-EFFECTIVENESS RESEARCH SPONSORED BY PHARMACEUTICAL COMPANIES
    HILLMAN, AL
    EISENBERG, JM
    PAULY, MV
    BLOOM, BS
    GLICK, H
    KINOSIAN, B
    SCHWARTZ, JS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) : 1362 - 1365
  • [25] TYING CLINICAL RESEARCH TO PATIENT-CARE BY USE OF AN OBSERVATIONAL DATABASE
    HLATKY, MA
    LEE, KL
    HARRELL, FE
    CALIFF, RM
    PRYOR, DB
    MARK, DB
    ROSATI, RA
    [J]. STATISTICS IN MEDICINE, 1984, 3 (04) : 375 - 384
  • [26] Are SSRIs a cost-effective alternative to tricyclics?
    Hotopf, M
    Lewis, G
    Normand, C
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1996, 168 (04) : 404 - 409
  • [27] IEZZONI LI, 1992, 920056 AG HLTH CAR P, P83
  • [28] COMPARING SOURCES OF DRUG DATA ABOUT THE ELDERLY
    JOHNSON, RE
    VOLLMER, WM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (11) : 1079 - 1084
  • [29] DISCORDANCE OF DATABASES DESIGNED FOR CLAIMS PAYMENT VERSUS CLINICAL INFORMATION-SYSTEMS - IMPLICATIONS FOR OUTCOMES RESEARCH
    JOLLIS, JG
    ANCUKIEWICZ, M
    DELONG, ER
    PRYOR, DB
    MUHLBAIER, LH
    MARK, DB
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 844 - 850
  • [30] ADEQUACY AND DURATION OF ANTIDEPRESSANT TREATMENT IN PRIMARY CARE
    KATON, W
    VONKORFF, M
    LIN, E
    BUSH, T
    ORMEL, J
    [J]. MEDICAL CARE, 1992, 30 (01) : 67 - 76